CN117285402A - Preparation method of pregabalin intermediate - Google Patents
Preparation method of pregabalin intermediate Download PDFInfo
- Publication number
- CN117285402A CN117285402A CN202311187175.3A CN202311187175A CN117285402A CN 117285402 A CN117285402 A CN 117285402A CN 202311187175 A CN202311187175 A CN 202311187175A CN 117285402 A CN117285402 A CN 117285402A
- Authority
- CN
- China
- Prior art keywords
- reaction
- organic layer
- preparation
- hexamethoxybiphenyl
- dimethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 title claims abstract description 24
- 229960001233 pregabalin Drugs 0.000 title claims abstract description 24
- 239000003054 catalyst Substances 0.000 claims abstract description 33
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims abstract description 27
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 claims abstract description 14
- 238000007259 addition reaction Methods 0.000 claims abstract description 9
- 239000003960 organic solvent Substances 0.000 claims abstract description 5
- 230000009471 action Effects 0.000 claims abstract description 3
- 239000003513 alkali Substances 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 64
- 239000012044 organic layer Substances 0.000 claims description 62
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 50
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 38
- 239000000203 mixture Substances 0.000 claims description 36
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 27
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 25
- 239000000243 solution Substances 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 17
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 16
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 238000010898 silica gel chromatography Methods 0.000 claims description 14
- CZWSUVQCPWIYID-HWKANZROSA-N (e)-4-methyl-1-nitropent-1-ene Chemical compound CC(C)C\C=C\[N+]([O-])=O CZWSUVQCPWIYID-HWKANZROSA-N 0.000 claims description 13
- LDNJAYXBFULWAN-UHFFFAOYSA-N COC(C=C(CO)C(C(C(CO)=C(C(C=C1F)=CC(F)=C1F)C(OC)=C1OC)=C1OC)=C1OC)=C1OC Chemical compound COC(C=C(CO)C(C(C(CO)=C(C(C=C1F)=CC(F)=C1F)C(OC)=C1OC)=C1OC)=C1OC)=C1OC LDNJAYXBFULWAN-UHFFFAOYSA-N 0.000 claims description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 10
- 238000010791 quenching Methods 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 7
- 239000012299 nitrogen atmosphere Substances 0.000 claims description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 7
- 230000035484 reaction time Effects 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 7
- 238000004809 thin layer chromatography Methods 0.000 claims description 7
- 230000032798 delamination Effects 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- UHDDEIOYXFXNNJ-UHFFFAOYSA-N (3,4,5-trifluorophenyl)boronic acid Chemical compound OB(O)C1=CC(F)=C(F)C(F)=C1 UHDDEIOYXFXNNJ-UHFFFAOYSA-N 0.000 claims description 5
- FCPDNFKGPVOOKP-UHFFFAOYSA-N (S)-4,5,6,4',5',6'-hexamethoxybiphenyl-2,2'-dicarboxylic acid Natural products COC1=C(OC)C(OC)=CC(C(O)=O)=C1C1=C(C(O)=O)C=C(OC)C(OC)=C1OC FCPDNFKGPVOOKP-UHFFFAOYSA-N 0.000 claims description 5
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 5
- 239000012300 argon atmosphere Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 229920006395 saturated elastomer Polymers 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 4
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- COIOYMYWGDAQPM-UHFFFAOYSA-N tris(2-methylphenyl)phosphane Chemical compound CC1=CC=CC=C1P(C=1C(=CC=CC=1)C)C1=CC=CC=C1C COIOYMYWGDAQPM-UHFFFAOYSA-N 0.000 claims description 4
- 239000012267 brine Substances 0.000 claims description 3
- 230000000171 quenching effect Effects 0.000 claims description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims description 3
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 claims description 2
- 239000011261 inert gas Substances 0.000 claims description 2
- 125000003944 tolyl group Chemical group 0.000 claims description 2
- MGCFRTVQJFTSGV-SNVBAGLBSA-N diethyl 2-[(2s)-4-methyl-1-nitropentan-2-yl]propanedioate Chemical compound CCOC(=O)C([C@H](CC(C)C)C[N+]([O-])=O)C(=O)OCC MGCFRTVQJFTSGV-SNVBAGLBSA-N 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 239000000543 intermediate Substances 0.000 abstract description 13
- 230000015572 biosynthetic process Effects 0.000 abstract description 8
- 238000003786 synthesis reaction Methods 0.000 abstract description 8
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract description 5
- -1 nitromethyl Chemical group 0.000 abstract description 4
- IYXGSMUGOJNHAZ-UHFFFAOYSA-N Ethyl malonate Chemical compound CCOC(=O)CC(=O)OCC IYXGSMUGOJNHAZ-UHFFFAOYSA-N 0.000 abstract description 2
- 239000011734 sodium Substances 0.000 description 17
- 235000019439 ethyl acetate Nutrition 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 239000003480 eluent Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 8
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 5
- 239000004305 biphenyl Substances 0.000 description 4
- 235000010290 biphenyl Nutrition 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 150000002085 enols Chemical class 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 238000006845 Michael addition reaction Methods 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 125000004360 trifluorophenyl group Chemical group 0.000 description 2
- SJBYIGXWWGSEES-PMACEKPBSA-N (1s,2s)-1-n,2-n-dibenzylcyclohexane-1,2-diamine Chemical compound N([C@H]1CCCC[C@@H]1NCC=1C=CC=CC=1)CC1=CC=CC=C1 SJBYIGXWWGSEES-PMACEKPBSA-N 0.000 description 1
- IAKOZHOLGAGEJT-UHFFFAOYSA-N 1,1,1-trichloro-2,2-bis(p-methoxyphenyl)-Ethane Chemical compound C1=CC(OC)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(OC)C=C1 IAKOZHOLGAGEJT-UHFFFAOYSA-N 0.000 description 1
- NQRCAVZHOLYEBJ-ZIAGYGMSSA-N 1-[3,5-bis(trifluoromethyl)phenyl]-3-[(1r,2r)-2-(dimethylamino)cyclohexyl]thiourea Chemical compound CN(C)[C@@H]1CCCC[C@H]1NC(=S)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 NQRCAVZHOLYEBJ-ZIAGYGMSSA-N 0.000 description 1
- VPSXHKGJZJCWLV-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(1-ethylpiperidin-4-yl)oxypyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)OC1CCN(CC1)CC VPSXHKGJZJCWLV-UHFFFAOYSA-N 0.000 description 1
- KNDAEDDIIQYRHY-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(piperazin-1-ylmethyl)pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CN1CCNCC1 KNDAEDDIIQYRHY-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010036376 Postherpetic Neuralgia Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
- 229960000623 carbamazepine Drugs 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000028329 epileptic seizure Diseases 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960002870 gabapentin Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940000041 nervous system drug Drugs 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- 229960002790 phenytoin sodium Drugs 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 description 1
- FJPYVLNWWICYDW-UHFFFAOYSA-M sodium;5,5-diphenylimidazolidin-1-ide-2,4-dione Chemical compound [Na+].O=C1[N-]C(=O)NC1(C=1C=CC=CC=1)C1=CC=CC=C1 FJPYVLNWWICYDW-UHFFFAOYSA-M 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 229960000604 valproic acid Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B53/00—Asymmetric syntheses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/0234—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
- B01J31/0235—Nitrogen containing compounds
- B01J31/0239—Quaternary ammonium compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/0234—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
- B01J31/0271—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds also containing elements or functional groups covered by B01J31/0201 - B01J31/0231
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention belongs to the technical field of synthesis of medical intermediates, and particularly relates to a preparation method of a pregabalin intermediate, which comprises the following steps of: in an organic solvent, under the action of a quaternary ammonium salt catalyst with the mass of 0.005-0.025 times of diethyl malonate and alkali, carrying out conjugated addition reaction for 4-6 hours at the temperature of minus 10-25 ℃ to obtain the pregabalin intermediate 1, 3-diethyl 2- [ (1S) -3-methyl-1- (nitromethyl) butyl]Malonic ester, wherein the quaternary ammonium salt catalyst is
Description
Technical Field
The invention belongs to the technical field of synthesis of medical intermediates, and particularly relates to a preparation method of a pregabalin intermediate.
Background
Epilepsy is a relatively common chronic neurological disorder, the second most common neurological disorder to headache. The drug therapy is the main therapeutic means for controlling epileptic seizure, and common antiepileptic drugs include Le Ruika, carbamazepine, phenobarbital, phenytoin sodium, valproate sodium and the like.
Le Ruika also called as pregabalin capsule, pregabalin is a novel, efficient and durable nervous system drug developed by the company Pfizer of the american type, and can be used for treating diseases such as postherpetic neuralgia, partial seizure epilepsy, anxiety and the like, and is approved to be marketed in China in 2010. Compared with the previous generation of nervous system medicine gabapentin capsules, the Lerui card has the advantages of easy absorption, obvious effect, high bioavailability, low medicine taking dosage, difficult generation of drug resistance, drug resistance and the like, and simultaneously has the characteristic of linear pharmacokinetics and can accurately control the effect of the treatment course. At present, le Ruika has very good market and application prospect as a nervous system medicament with remarkable effect.
Pregabalin intermediates are often prepared by asymmetric conjugate addition reactions in which, although products can be obtained with excellent enantioselectivities and yields under metal catalysis, disadvantages such as severe reaction conditions, high toxicity, or expensive catalysts are unavoidable.
Asymmetric conjugate addition of pregabalin intermediates without metal catalysts has been reported:
(1) N- [3, 5-bis (trifluoromethyl) phenyl ] -N' - [ (1R, 2R) -2- (dimethylamino) cyclohexyl ] thiourea (chemform, 2011,67 (3): 636-640):
the catalyst has complex preparation, high price and long reaction time of 24 hours.
(2) N- [3, 5-bis (trifluoromethyl) phenyl ] -N' - [ (3 aR,5S,6 aR) -tetrahydro-2, 2-dimethyl-6- [ (phenylmethyl) amino ] furo [2,3-d ] -1, 3-dioxo-5-yl ] thiourea (Organic & Biomolecular Chemistry,2016,14 (48): 11454-11461.):
the method has the advantages of harsh reaction conditions, long reaction time, high price of the catalyst and high synthesis cost.
(3) (1 s,2 s) -N1, N2-bis (phenylmethyl) -1, 2-cyclohexanediamine (RU 2555370):
the method also has the problems of high price of the catalyst and high synthesis cost.
Therefore, the prior asymmetric catalytic pregabalin intermediate synthesis has the defects of high cost, long reaction time, low efficiency and the like, and brings great trouble to practical application. Therefore, the synthesis process of the pregabalin intermediate with low development cost, simple operation and high product purity has important value.
Disclosure of Invention
In order to solve the technical problems, the invention provides a preparation method of a pregabalin intermediate, which comprises the following steps:
diethyl malonate and (1E) -4-methyl-1-nitro-1-pentene are catalyzed to generate conjugated addition reaction by a quaternary ammonium salt catalyst to generate the pregabalin intermediate 1, 3-diethyl 2- [ (1S) -3-methyl-1- (nitromethyl) butyl]Malonic ester, wherein the quaternary ammonium salt catalyst is
The catalytic reaction formula is:
as preferable: the quaternary ammonium salt catalyst is prepared by the following steps:
(1) Preparation of (S) -3,3' -dibromo-4,5,6,4 ',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol
BH was added under nitrogen atmosphere 3 ·SMe 2 To (S) -4,5,6,4',5',6 '-hexamethoxybiphenyl-2, 2' -dicarboxylic acid in THF/B (OMe) 3 Stirring the solution for 5 hours, adding methanol to quench the reaction, removing the solvent under reduced pressure, adding hydrochloric acid into the residue, adding ethyl acetate for extraction after mixing, separating to obtain an organic layer after full layering, drying the organic layer, concentrating the organic layer under reduced pressure, adding pyridine, THF and liquid bromine into the concentrated organic layer, stirring the mixture for 1 hour, pouring the obtained reaction system into saturated Na 2 SO 3 Separating the aqueous solution and ethyl acetate after fully layering to obtain an organic layer, drying the organic layer, concentrating the organic layer under reduced pressure, and purifying by a silica gel column chromatography to obtain (S) -3,3' -dibromo-4,5,6,4 ',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol;
(2) Preparation of (S) -3,3' -bis (3, 4, 5-trifluorophenyl) -4,5,6,4',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol
Adding (S) -3,3' -dibromo-4,5,6,4 ',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol, 3,4, 5-trifluoro phenylboronic acid, palladium acetate, tris (o-methylphenyl) phosphorus and K obtained in the step (1) into a flask under the atmosphere of nitrogen 3 PO 4 -nH 2 O and tetrahydrofuran solution are fully mixed and then heated for reaction, the reaction is monitored by thin layer chromatography until the signal of the raw material (S) -3,3 '-dibromo-4,5,6,4', 5',6' -hexamethoxybiphenyl-2, 2 '-dimethanol disappears, the obtained reaction system is filtered, the filtrate is concentrated in vacuum, and the filtrate is purified by silica gel column chromatography to obtain (S) -3,3' -bis (3, 4, 5-trifluorophenyl) -4,5,6,4',5',6 '-hexamethoxybiphenyl-2, 2' -dimethanol;
(3) PBr is put into 3 (S) -3,3' -bis (3, 4, 5-trifluorophenyl) 4,5,6,4',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol obtained in step (2) is added to CH 2 Cl 2 Adding water into the mixture to quench the reaction after stirring the reaction, adding diethyl ether into the mixture to extract the mixture,after sufficient delamination, the organic layer was separated, washed with brine, dried, concentrated under reduced pressure, and the concentrated system was put into K under argon atmosphere 2 CO 3 And Bu (Bu) 2 Adding the mixture into acetonitrile suspension of NH, fully mixing and heating for reaction, pouring the obtained mixed system into HBr aqueous solution for quenching, adding CH 2 Cl 2 Extraction is carried out, after sufficient delamination, an organic layer is separated, the organic layer is dried, and the organic layer is concentrated under reduced pressure and then purified by silica gel column chromatography.
Further: in the step (1), pyridine and THF are added into the concentrated organic layer, the obtained mixture is cooled to-20 ℃, liquid bromine is added into the mixture, and the mixture is heated to 0 ℃ and then stirred for reaction for 1 hour.
Further: in the step (2), the temperature of the heating reaction was 88 ℃.
Further: in the step (3), the temperature of the heating reaction is 80 ℃ and the reaction time is 10 hours.
As preferable: the mass ratio of the diethyl malonate to the (1E) -4-methyl-1-nitro-1-pentene to the quaternary ammonium salt catalyst is 1:0.8 to 1.6: 0.005-0.025.
As preferable: under the protection of inert gas, diethyl malonate and (1E) -4-methyl-1-nitro-1-pentene are subjected to conjugate addition reaction in an organic solvent under the action of a quaternary ammonium salt catalyst and alkali.
Further: the organic solvent is toluene, DMF or acetonitrile.
Further: the reaction temperature of the conjugate addition reaction is-10 ℃ to 25 ℃ and the reaction time is 4 hours to 6 hours.
When the quaternary ammonium salt catalyst is used for catalyzing synthesis of diethyl malonate and (1E) -4-methyl-1-nitro-1-pentene, electronegativity is reflected after diethyl malonate of one reactant is converted into enol, ion pair combination is formed with quaternary ammonium salt functional groups, and an oxygen atom with negative charges on nitro on (1E) -4-methyl-1-nitro-1-pentene biphenyl and nitrogen on the quaternary ammonium salt have interaction of heterogeneous charges, so that the effect of fixing the relative positions of reaction molecules is achieved. When the addition reaction occurs, the carbon atom with partial negative charge on enol type attacks the double bond of (1E) -4-methyl-1-nitro-1-pentene to generate Michael addition reaction, and two large steric hindrance trifluorophenyl groups on chiral biphenyl enable the situation that the carbon atom attacks from one side to occupy absolute advantages in the reaction, thereby effectively improving the enantioselectivity of the reaction and leading the proportion of high-activity configuration in the product to be higher, and the mechanism is as follows:
meanwhile, the catalyst of the invention has low dosage and low cost, has higher industrialized value, safe and environment-friendly process, high yield and simple operation, and therefore, the cost of the prepared pregabalin intermediate is relatively lower.
Detailed Description
The invention is further described in connection with the following examples (the raw materials used in the following examples are all technical grade products):
the preparation method of the quaternary ammonium salt catalyst comprises the following steps:
(1) Preparation of (S) -3,3' -dibromo-4,5,6,4 ',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol
BH at 0℃under nitrogen atmosphere 3 ·SMe 2 (4.0 mmol) in tetrahydrofuran (4.0 mL) was added dropwise to a solution of (S) -4,5,6,4',5',6 '-hexamethoxybiphenyl-2, 2' -dicarboxylic acid (1.0 mmol) in THF/B (OMe) at 0deg.C 3 (4 mL/2 mL) of the solution, the temperature of the resulting mixed system was raised to room temperature (25 ℃ C., the same applies hereinafter) and then the reaction was continued with stirring for 5 hours, 1mL of methanol was slowly added thereto to quench the reaction, then the solvent was removed under reduced pressure, 8.0mL of 1N hydrochloric acid was added to the residue, the mixture was thoroughly mixed and then ethyl acetate was added to extract, and after sufficient delamination, an organic layer was obtained by separation, and Na was used 2 SO 4 Drying the organic layer, concentrating under reduced pressure, adding pyridine (0.57 mL) and THF (5 mL) into the concentrated organic layer, mixing, cooling to-20deg.C, adding liquid bromine (0.36 mL,7.0 mmol) into the mixture, heating to 0deg.C, stirring, reacting for 1 hr, and pouring the obtained reaction systemInto saturated Na 2 SO 3 Separating the aqueous solution and ethyl acetate to obtain an organic layer, and separating the organic layer with Na 2 SO 4 Drying the organic layer, concentrating the organic layer under reduced pressure, and purifying by silica gel column chromatography (petroleum ether/ethyl acetate volume ratio 1:1 as eluent) to obtain (S) -3,3' -dibromo-4,5,6,4 ',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol;
(2) Preparation of (S) -3,3' -bis (3, 4, 5-trifluorophenyl) -4,5,6,4',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol:
(S) -3,3' -dibromo-4,5,6,4 ',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol (0.276 g), 3,4, 5-trifluorophenylboronic acid (0.440 g,2.5 mmol), palladium acetate (0.0225 g,0.10 mmol), tris (o-methylphenyl) phosphorus (0.122 g,0.40 mmol), K obtained in step (1) were charged to a flask under a nitrogen atmosphere 3 PO 4 -nH 2 O (1.056 g,5.0 mmol) and tetrahydrofuran solution (5 mL), heating to 88 ℃ after mixing fully, stirring and reacting, monitoring the reaction by Thin Layer Chromatography (TLC) until the signal of the raw material (S) -3,3 '-dibromo-4,5,6,4', 5',6' -hexamethoxybiphenyl-2, 2 '-dimethanol disappears, filtering the obtained reaction system, concentrating the filtrate in vacuum, and purifying by silica gel column chromatography (petroleum ether/ethyl acetate volume ratio 2:1 is used as eluent) to obtain (S) -3,3' -bis (3, 4, 5-trifluorophenyl) -4,5,6,4',5',6 '-hexamethoxybiphenyl-2, 2' -dimethanol;
(3) PBr at 0deg.C 3 (0.038 mL,0.4 mmol), and (S) -3,3' -bis (3, 4, 5-trifluorophenyl) 4,5,6,4',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol (0.2 mmol) obtained in step (2) were added to CH 2 Cl 2 (5 mL) the resulting mixture was allowed to stand at room temperature for 1 hour with stirring, quenched with water, extracted with diethyl ether, separated to give an organic layer, washed with Na 2 SO 4 Drying the organic layer, concentrating the organic layer under reduced pressure, and charging the concentrated solution into K under argon atmosphere 2 CO 3 (0.0553 g,0.40 mmol) and Bu 2 In a suspension of NH (0.037 mL,0.22 mmol) in acetonitrile (5 mL), mixing was complete and warmed to 80 ℃After heating for 10 hours, the resulting mixture was poured into 5.0mL of 1N aqueous HBr solution and quenched, and CH was added 2 Cl 2 Extracting, fully layering, separating to obtain an organic layer, and using Na 2 SO 4 The organic layer was dried and concentrated under reduced pressure, followed by column chromatography on silica gel (MeOH/CH 2 Cl 2 Volume ratio 1:10 as eluent).
Example 1
Synthesis of 1, 3-diethyl 2- [ (1S) -3-methyl-1- (nitromethyl) butyl ] malonate
Under the protection of argon gas, (1E) -4-methyl-1-nitro-1-pentene (563.82 mg,4.37 mmol) and diethyl malonate (500 mg,3.12 mmol) were added to the flask, and after 20mL of toluene was added for sufficient dissolution, the reaction was started at room temperature after adding the above prepared quaternary ammonium salt catalyst (252.1 mg,0.0312 mmol) thereto, and the reaction was monitored by TLC under stirring for 6 hours, and after concentrating the obtained reaction system under vacuum, the obtained reaction system was purified by silica gel column chromatography (hexane/ethyl acetate volume ratio 5:1 as eluent) to obtain the objective product (794 mg,88.0% where "88.0%" is the yield, calculated by mol of diethyl malonate in the objective product × 100%, the same applies below) with an ee value of 92%.
Characterization of the product structure: 1 H NMR(400MHz,CDCl 3 )δ4.71(dd,J=13.3,5.0Hz,1H),4.53(dd,J=13.3,6.6Hz,1H),4.31-4.14(m,4H),3.62(d,J=5.5Hz,1H),3.07-2.82(m,1H),1.73-1.57(m,1H),1.36-1.25(m,8H),0.95-0.89(m,6H)ppm;ESI-MS[M+H + ]:290.
examples 2 to 5
On the basis of example 1, other experimental conditions were kept unchanged, and the effect on the reaction results was examined only by changing the ratio of the amounts of the materials of diethyl malonate and (1E) -4-methyl-1-nitro-1-pentene and compared with example 1, and the results obtained are shown in table 1:
TABLE 1
From Table 1, it was found that the ratio of the amounts of the materials of diethyl malonate and (1E) -4-methyl-1-nitro-1-pentene was 1:1.4 is most preferable, and the molar ratio is further increased, and the yield does not change much.
Examples 6 to 9
On the basis of example 1, other experimental conditions were kept unchanged, and the effect on the reaction results was examined by merely changing the percentage of the amount of the quaternary ammonium salt catalyst with respect to the diethyl malonate, and compared with example 1, and the results obtained are shown in table 2:
TABLE 2
As can be seen from Table 2, the catalyst amount was most suitably 1%, and the yield was not greatly changed by further increasing the amount.
Examples 10 to 13
On the basis of example 1, other experimental conditions were kept unchanged, and the effect on the reaction results was examined by merely changing the reaction temperature and compared with example 1, and the results obtained are shown in table 3:
TABLE 3 Table 3
Reaction temperature | Yield is good | ee value | |
Example 1 | 25℃ | 88.0% | 92% |
Example 10 | -10℃ | 80.2% | 92% |
Example 11 | 0℃ | 80.4% | 91% |
Example 12 | 10℃ | 83.5% | 88% |
Example 13 | 35℃ | 87.3% | 87% |
As can be seen from Table 3, when the reaction temperature was 25 ℃, higher yields and ee values were obtained at the same time.
Examples 14 to 16
On the basis of example 1, other experimental conditions were kept unchanged, and the effect on the reaction results was examined by merely changing the reaction solvent and compared with example 1, and the results obtained are shown in table 4:
TABLE 4 Table 4
Reaction solvent | Yield is good | ee value | |
Example 1 | Toluene (toluene) | 88.0% | 92% |
Example 10 | Acetonitrile | 80.2% | 90% |
Example 11 | DMF | 84.4% | 85% |
Example 12 | DMSO | 82.5% | 87% |
As can be seen from Table 4, when the solvent was toluene, high yields and ee values were obtained.
Example 17
On the basis of example 1, other experimental conditions were kept unchanged, and the effect on the reaction results was examined by merely changing the molecular structure composition of the catalyst and compared with example 1, and the results obtained are shown in table 5:
in this example, 3,4, 5-trifluorophenylboronic acid is not added in the preparation method of the quaternary ammonium salt catalyst, and the rest of the operations are the same as in example 1:
(1) BH at 0℃under nitrogen atmosphere 3 ·SMe 2 (4.0 mmol) in tetrahydrofuran (4.0 mL) was added dropwise to a solution of (S) -4,5,6,4',5',6 '-hexamethoxybiphenyl-2, 2' -dicarboxylic acid (1.0 mmol) in THF/B (OMe) at 0deg.C 3 (4 mL/2 mL) of the solution, the temperature of the resulting mixed system was raised to room temperature (25 ℃ C., the same applies hereinafter) and then the reaction was continued with stirring for 5 hours, 1mL of methanol was slowly added thereto to quench the reaction, then the solvent was removed under reduced pressure, 8.0mL of 1N hydrochloric acid was added to the residue, the mixture was thoroughly mixed and then ethyl acetate was added to extract, and after sufficient delamination, an organic layer was obtained by separation, and Na was used 2 SO 4 The organic layer was dried, concentrated under reduced pressure, pyridine (0.57 mL) and THF (5 mL) were added to the concentrated organic layer, the mixture was cooled to-20℃after sufficient mixing, liquid bromine (0.36 mL,7.0 mmol) was added to the mixture, the mixture was heated to 0℃again, and the mixture was stirred for 1 hour to allow the reaction system to react, and saturated Na was added to the reaction system 2 SO 3 Separating the aqueous solution and ethyl acetate to obtain an organic layer, and separating the organic layer with Na 2 SO 4 Drying the organic layer, concentrating the organic layer under reduced pressure, and purifying by silica gel column chromatography (petroleum ether/ethyl acetate volume ratio 1:1 as eluent) to obtain (S) -3,3' -dibromo-4,5,6,4 ',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol;
(2) PBr at 0deg.C 3 (0.038 mL,0.4 mmol), and (S) -3,3' -dibromo-4,5,6,4 ',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol (0.2 mmol) obtained in step (1) were added to CH 2 Cl 2 (5 mL) the resulting mixture was allowed to stand at room temperature for 1 hour with stirring, quenched with water, extracted with diethyl ether, separated to give an organic layer, washed with Na 2 SO 4 Drying the organic layerConcentrating the organic layer under reduced pressure, and introducing the concentrated solution into K under argon atmosphere 2 CO 3 (0.0553 g,0.40 mmol) and Bu 2 In a suspension of NH (0.037 mL,0.22 mmol) in acetonitrile (5 mL), the mixture was thoroughly mixed and heated to 80℃for 10 hours, the resulting mixture was poured into 5.0mL of 1N aqueous HBr solution and quenched, and CH was added 2 Cl 2 Extracting, fully layering, separating to obtain an organic layer, and using Na 2 SO 4 The organic layer was dried and concentrated under reduced pressure, followed by column chromatography on silica gel (MeOH/CH 2 Cl 2 Volume ratio 1:10 as eluent).
TABLE 5
Yield is good | ee value | |
Example 1 | 88.0% | 92% |
Example 17 | 82.1% | 78% |
As shown in the table above, in this example, after the biphenyl structure of the quaternary ammonium salt catalyst loses the benzene ring side group, when the Michael addition reaction occurs, the limitation effect of the corresponding carbon atom on the enol on the attack direction of (1E) -4-methyl-1-nitro-1-pentene is greatly weakened, so that the controllability of the reaction is correspondingly reduced, the by-product is increased, and the selectivity of the product is also reduced.
Example 18
On the basis of example 1, other experimental conditions were kept unchanged, and the effect on the reaction results was examined by merely changing the molecular structure composition of the catalyst and compared with example 1, and the results obtained are shown in table 6:
in this example, the "Bu" in step (3) was used in the preparation method of the quaternary ammonium salt catalyst 2 NH "replaced with" diethylamine ", the rest of the procedure being the same as in example 1:
(1) Preparation of (S) -3,3' -dibromo-4,5,6,4 ',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol
BH at 0℃under nitrogen atmosphere 3 ·SMe 2 (4.0 mmol) in tetrahydrofuran (4.0 mL) was added dropwise to a solution of (S) -4,5,6,4',5',6 '-hexamethoxybiphenyl-2, 2' -dicarboxylic acid (1.0 mmol) in THF/B (OMe) at 0deg.C 3 (4 mL/2 mL) of the solution, the temperature of the resulting mixed system was raised to room temperature (25 ℃ C., the same applies hereinafter) and then the reaction was continued with stirring for 5 hours, 1mL of methanol was slowly added thereto to quench the reaction, then the solvent was removed under reduced pressure, 8.0mL of 1N hydrochloric acid was added to the residue, the mixture was thoroughly mixed and then ethyl acetate was added to extract, and after sufficient delamination, an organic layer was obtained by separation, and Na was used 2 SO 4 The organic layer was dried, concentrated under reduced pressure, pyridine (0.57 mL) and THF (5 mL) were added to the concentrated organic layer, the mixture was cooled to-20℃after sufficient mixing, liquid bromine (0.36 mL,7.0 mmol) was added to the mixture, the mixture was heated to 0℃again, and the mixture was stirred for 1 hour to allow the reaction system to react, and saturated Na was added to the reaction system 2 SO 3 Separating the aqueous solution and ethyl acetate to obtain an organic layer, and separating the organic layer with Na 2 SO 4 Drying the organic layer, concentrating the organic layer under reduced pressure, and purifying by silica gel column chromatography (petroleum ether/ethyl acetate volume ratio 1:1 as eluent) to obtain (S) -3,3' -dibromo-4,5,6,4 ',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol;
(2) Preparation of (S) -3,3' -bis (3, 4, 5-trifluorophenyl) -4,5,6,4',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol:
under nitrogen gasThe flask was charged with (S) -3,3' -dibromo-4,5,6,4 ',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol (0.276 g), 3,4, 5-trifluorophenylboronic acid (0.440 g,2.5 mmol), palladium acetate (0.0225 g,0.10 mmol), tris (o-methylphenyl) phosphorus (0.122 g,0.40 mmol), K obtained in step (1) under an atmosphere 3 PO 4 -nH 2 O (1.056 g,5.0 mmol) and tetrahydrofuran solution (5 mL), heating to 88 ℃ after mixing fully, stirring and reacting, monitoring the reaction by Thin Layer Chromatography (TLC) until the signal of the raw material (S) -3,3 '-dibromo-4,5,6,4', 5',6' -hexamethoxybiphenyl-2, 2 '-dimethanol disappears, filtering the obtained reaction system, concentrating the filtrate in vacuum, and purifying by silica gel column chromatography (petroleum ether/ethyl acetate volume ratio 2:1 is used as eluent) to obtain (S) -3,3' -bis (3, 4, 5-trifluorophenyl) -4,5,6,4',5',6 '-hexamethoxybiphenyl-2, 2' -dimethanol;
(3) PBr at 0deg.C 3 (0.038 mL,0.4 mmol), and (S) -3,3' -bis (3, 4, 5-trifluorophenyl) 4,5,6,4',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol (0.2 mmol) obtained in step (2) were added to CH 2 Cl 2 (5 mL) the resulting mixture was allowed to stand at room temperature for 1 hour with stirring, quenched with water, extracted with diethyl ether, separated to give an organic layer, washed with Na 2 SO 4 Drying the organic layer, concentrating the organic layer under reduced pressure, and charging the concentrated solution into K under argon atmosphere 2 CO 3 (0.0553 g,0.40 mmol) and diethylamine (0.023 mL,0.22 mmol) in acetonitrile (5 mL), mixing thoroughly and heating to 80deg.C for reaction for 10h, pouring the resulting mixture into 5.0mL of 1N aqueous HBr for quenching, adding CH 2 Cl 2 Extracting, fully layering, separating to obtain an organic layer, and using Na 2 SO 4 The organic layer was dried and concentrated under reduced pressure, followed by column chromatography on silica gel (MeOH/CH 2 Cl 2 Volume ratio 1:10 as eluent).
TABLE 6
Yield is good | ee value | |
Example 1 | 88.0% | 92% |
Example 18 | 84.6% | 87% |
As shown in the table above, in this example, after the butyl segment on the catalyst close to the molecular position of the reactant becomes a shorter ethyl group, the reaction controllability is reduced, probably because the butyl segment on the catalyst structure has a certain limited influence on the attack direction between the reactants based on the chain length of the butyl segment, but the influence is smaller than that of the large-steric-hindrance trifluorophenyl group on the biphenyl.
Example 19
On the basis of example 1, other experimental conditions were kept unchanged, and the effect on the reaction results was examined by merely changing the molecular structure composition of the catalyst and compared with example 1, and the results obtained are shown in table 7:
in this embodiment, the preparation method of the quaternary ammonium salt catalyst is as follows:
after a dialdehyde compound (440 mg,1 mmol), methylamino acid hydrogen chloride (1.5 mmol), sodium cyanoborohydride (330 mg,3 mmol) and 20mL methanol were added to a 50mL flask, the reaction was stirred at room temperature for 4 hours, the resultant reaction mixture was diluted with EtOAc, washed with brine, and left to stand until the layers were separatedSeparating, separating and retaining the organic phase, and subjecting the obtained organic phase to anhydrous Na 2 SO 4 Dried, concentrated, and purified by silica gel column chromatography to give the corresponding N, N-disubstituted amine, dissolving the resulting N, N-disubstituted amine (0.2 mmol) and allyl bromide (0.4 mmol) in 5mL acetonitrile, and reacting for 2 days at room temperature with stirring, then using CH 2 Cl 2 After diluting the resulting reaction system mixture, the solvent and allyl bromide were removed by vacuum concentration, and the residue was purified by silica gel column chromatography (CH 2 Cl 2 MeOH volume ratio 10:1 as eluent). The preparation formula is as follows:
wherein, by changing the structure of R on methyl amino acid hydrogen chloride molecule, respectively obtaining quaternary ammonium salt 1 and quaternary ammonium salt 2, the molecular structure is as follows:
quaternary ammonium salt 1:
H NMR(300MHz,CDCl3)δ3.26(t,1H,J=12.0Hz),3.61(s,3H),3.72-3.81(m,7H),3.90-4.00(m,14H),4.51-4.66(m,2H),4.80(d,1H,J=9.0Hz),5.40(d,1H,J=13.2Hz),5.56-5.64(m,3H),6.30-6.43(m,1H),7.24-7.30(m,5H),7.53(s,1H),7.67(s,1H);13C NMR(100MHz,CDCl3)δ32.8,52.8,55.9,56.4,60.45,60.46,60.57,60.62 62.9,64.1,73.0,110.3,111.1,121.9,122.8,124.8,127.2,127.6,128.2,129.0,132.6,143.2,143.3,151.18,151.24,153.3,166.3ppm.ESI-MS:578.1(M+-Br);HRMS(ESI)for C 33 H 40 N 1 O 2 (M+-Br):calcd 578.2754,found578.275;
quaternary ammonium salt 2:
H NMR(300MHz,CDCl3)δ0.68(d,3H,J=6.3Hz),0.72(d,3H,J=6.6Hz),1.37(br,1H),1.85-2.05(m,2H),3.31(d,1H,J=12.6Hz),3.51(s,6H),3.57(d,1H,13.8Hz),3.73(s,3H),3.75(s,6H),3.80(d,6H,J=1.5Hz),4.12(d,1H,J=12.9Hz),4.22-4.29(m,1H),4.39-4.46(m,1H),4.67(d,1H,J=13.5Hz),5.34-5.45(m,3H),6.02-6.16(m,1H),7.02(s,1H),7.50(s,1H);13CNMR(100MHz,CDCl3)δ20.8,22.7,25.4,34.6,53.6,55.9,56.5,60.5,60.56,60.61,62.7,63.2,70.9,110.0,111.3,122.1,122.3,122.7,123.0,125.4,127.5,143.3,143.4,151.1,151.3,153.0,153.4,167.1ppm.ESI-MS:544.1(M+-Br);HRMS(ESI)for C 30 H 42 N 1 O 8 (M+-Br):calcd 544.2910,found544.2896.
TABLE 7
As shown in the table above, in this example, after the biphenyl structure of the quaternary ammonium salt catalyst loses the benzene ring side group, when the Michael addition reaction occurs, the limitation effect of the corresponding carbon atom on the enol on the attack direction of (1E) -4-methyl-1-nitro-1-pentene is greatly weakened, so that the controllability of the reaction is correspondingly reduced, the by-product is increased, and the selectivity of the product is also reduced.
Claims (9)
1. A method for preparing pregabalin intermediate, which is characterized in that: the preparation method is that,
through a quaternary ammonium salt catalyst, diethyl malonate and (1E) -4-methyl-1-nitro-1-pentene are catalyzed to generate conjugated addition reaction to generate the pregabalin intermediate 1, 3-diethyl 2- [ (1S) -3-methyl-1- (nitromethyl) butyl]Malonate, wherein the quaternary ammonium salt catalyst is
2. A process for the preparation of pregabalin intermediate according to claim 1, characterized in that: the preparation method of the quaternary ammonium salt catalyst comprises the following steps of,
(1) Preparation of (S) -3,3' -dibromo-4,5,6,4 ',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol
BH was added under nitrogen atmosphere 3 ·SMe 2 To (S) -4,5,6,4',5',6 '-hexamethoxybiphenyl-2, 2' -dicarboxylic acid in THF/B (OMe) 3 Stirring the solution for 5 hours, adding methanol to quench the reaction, removing the solvent under reduced pressure, adding hydrochloric acid into the residue, adding ethyl acetate for extraction after mixing, separating to obtain an organic layer after full layering, drying the organic layer, concentrating the organic layer under reduced pressure, adding pyridine, THF and liquid bromine into the concentrated organic layer, stirring the mixture for 1 hour, pouring the obtained reaction system into saturated Na 2 SO 3 Separating the aqueous solution and ethyl acetate after fully layering to obtain an organic layer, drying the organic layer, concentrating the organic layer under reduced pressure, and purifying by a silica gel column chromatography to obtain the (S) -3,3' -dibromo-4,5,6,4 ',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol;
(2) Preparation of (S) -3,3' -bis (3, 4, 5-trifluorophenyl) -4,5,6,4',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol
Adding the (S) -3,3' -dibromo-4,5,6,4 ',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol, 3,4, 5-trifluorophenylboronic acid, palladium acetate, tris (o-methylphenyl) phosphorus, K obtained in the step (1) into a flask under a nitrogen atmosphere 3 PO 4 -nH 2 O and tetrahydrofuran solution are fully mixed and then heated for reaction, the reaction is monitored by thin layer chromatography until the signal of the raw material (S) -3,3 '-dibromo-4,5,6,4', 5',6' -hexamethoxybiphenyl-2, 2 '-dimethanol disappears, the obtained reaction system is filtered, the filtrate is concentrated in vacuum, and the (S) -3,3' -bis (3, 4, 5-trifluorophenyl) -4,5,6,4',5',6 '-hexamethoxybiphenyl-2, 2' -dimethanol is obtained by purifying the filtrate by silica gel column chromatography;
(3) PBr is put into 3 Adding the (S) -3,3' -bis (3, 4, 5-trifluorophenyl) 4,5,6,4',5',6' -hexamethoxybiphenyl-2, 2' -dimethanol obtained in the step (2) to CH 2 Cl 2 Adding water to quench the reaction after stirring the reaction, and then adding diethyl ether to extractTaking, fully layering, separating to obtain an organic layer, washing the organic layer with brine, drying the organic layer, concentrating the organic layer under reduced pressure, and putting the system after reduced pressure concentration into K under argon atmosphere 2 CO 3 And Bu (Bu) 2 Adding the mixture into acetonitrile suspension of NH, fully mixing and heating for reaction, pouring the obtained mixed system into HBr aqueous solution for quenching, adding CH 2 Cl 2 Extraction is carried out, after sufficient delamination, an organic layer is separated, the organic layer is dried, and the organic layer is concentrated under reduced pressure and then purified by silica gel column chromatography.
3. A process for the preparation of pregabalin intermediate according to claim 2, characterized in that: in the step (1), after pyridine and THF are added into the concentrated organic layer, the obtained mixture is cooled to-20 ℃, then the liquid bromine is added into the mixture, and the mixture is heated to 0 ℃ and then stirred for reaction for 1 hour.
4. A process for the preparation of pregabalin intermediate according to claim 2, characterized in that: in the step (2), the temperature of the heating reaction is 88 ℃.
5. A process for the preparation of pregabalin intermediate according to claim 2, characterized in that: in the step (3), the temperature of the heating reaction is 80 ℃ and the reaction time is 10 hours.
6. A process for the preparation of pregabalin intermediate according to claim 1, characterized in that: the mass ratio of the diethyl malonate, the (1E) -4-methyl-1-nitro-1-pentene and the quaternary ammonium salt catalyst is 1:0.8 to 1.6: 0.005-0.025.
7. A process for the preparation of pregabalin intermediate according to claim 1, characterized in that: under the protection of inert gas, diethyl malonate and (1E) -4-methyl-1-nitro-1-pentene are subjected to the conjugate addition reaction in an organic solvent under the action of the quaternary ammonium salt catalyst and alkali.
8. A process for the preparation of pregabalin intermediate according to claim 8, characterized in that: the organic solvent is toluene, DMF or acetonitrile.
9. A process for the preparation of pregabalin intermediate according to claim 8, characterized in that: the reaction temperature of the conjugate addition reaction is-10 ℃ to 25 ℃ and the reaction time is 4 hours to 6 hours.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311187175.3A CN117285402A (en) | 2023-09-14 | 2023-09-14 | Preparation method of pregabalin intermediate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311187175.3A CN117285402A (en) | 2023-09-14 | 2023-09-14 | Preparation method of pregabalin intermediate |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117285402A true CN117285402A (en) | 2023-12-26 |
Family
ID=89252834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311187175.3A Pending CN117285402A (en) | 2023-09-14 | 2023-09-14 | Preparation method of pregabalin intermediate |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117285402A (en) |
-
2023
- 2023-09-14 CN CN202311187175.3A patent/CN117285402A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017201846A1 (en) | Preparation method of antibacterial oxazolidinone medicine and intermediate thereof | |
CN101798271B (en) | Method for preparing (+/-)-norepinephrine | |
US8912345B2 (en) | Method for preparing optically pure (−)-clausenamide compound | |
CN107602399B (en) | Preparation method of enkephalinase inhibitor intermediate | |
CN103044468A (en) | Preparation method of N-(2-pyrazine carbonyl)-L-phenylalanine-L- leucine boracic acid | |
Maj et al. | Asymmetric hydrogenation of 2, 3-dihydro-1H-inden-1-one oxime and derivatives | |
WO2024017221A1 (en) | SYNTHESIS METHOD FOR α-AZIDO KETONE CONTAINING TERTIARY STEREOCENTER | |
CN117285402A (en) | Preparation method of pregabalin intermediate | |
CN114805167B (en) | Preparation method of brivaracetam | |
CN114621295B (en) | Chiral oxazoline palladium complex crystal and application thereof | |
CN109879800B (en) | Preparation process of bepotastine drug intermediate | |
Chen et al. | Synthesis of Novel Chiral Biphenylamine Ligand 6, 6'‐Dimethoxy‐2, 2′‐diaminobiphenyl | |
CN113980028A (en) | Preparation method of chiral spiro indolone compound | |
CN113527064A (en) | Preparation method of phloroglucinol | |
CN109265385B (en) | Synthesis process of chiral catalyst | |
CN113444040A (en) | Method for synthesizing chiral alpha-unnatural amino acid derivative under drive of visible light | |
CN115703806B (en) | Phosphine ligand of pyrazole-amide framework, and preparation method and application thereof | |
CN115819186B (en) | Novel preparation method of 3, 5-dichlorobenzyl alcohol | |
CN115286504B (en) | Method for synthesizing (R) -2- (2- (tert-butoxy) -2-oxyethyl) pentanoic acid | |
CN115260126B (en) | Chiral quaternary ammonium salt with (S) -binaphthyl, preparation method and application | |
CN114957305B (en) | Automatic synthesis method of mobile phase of anticancer drug Talabostat | |
CN111646889B (en) | Green synthesis method of drug active molecules GC-24 and furaldehyde | |
CN108503508B (en) | Synthetic method of anticoagulant ticagrelor raw material intermediate | |
CN110003147B (en) | Preparation method of polysubstituted 3-benzylidene tetrahydrofuran compound | |
CN106966942B (en) | A kind of preparation method of Ezetimibe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |